BioCentury
ARTICLE | Clinical News

Epi proColon regulatory update

January 6, 2014 8:00 AM UTC

Last month, French supplementary insurance provider Mutuelle d'Assurances du Corps de Sante Francais (MACSF) said it will provide Epi proColon for the early detection of colorectal cancer (CRC) as part of its additional health insurance program. Epigenomics markets Epi proColon test, which uses real-time PCR to detect methylated DNA of the Septin 9 gene in blood plasma, in Europe for the indication. ...